Language selection

Government of Canada / Gouvernement du Canada

Search

Issue identification paper : drug-device combination products (DDCPS) : draft for consultation.: H164-377/2021E-PDF

"This paper is intended to identify the key challenges associated with Health Canada’s oversight of drug-device combination products (DDCPs) as per Health Canada’s Policy on Drug/Medical Device Combination Products (the Policy). DDCPs are health products that combine drugs and medical devices as a single entity. For the purposes of this paper, a drug is considered to be a pharmaceutical, radiopharmaceutical, natural health product (NHP), biologic, cell, tissue, organ, gene therapy, or human blood and its components"--Objective, page 3.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.940313&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleIssue identification paper : drug-device combination products (DDCPS) : draft for consultation.
Variant title
  • Drug-device combination products (DDCPS)
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Documentation de détermination des enjeux : produits mixtes médicaments-instruments médicaux : ébauche aux fins de consultation.
  • "Draft date: 2021/05/10."
  • Includes bibliographical references (page 13).
Publishing information
  • [Ottawa] : Health Canada = Santé Canada, May 10, 2021.
Description1 online resource (13 pages)
Catalogue number
  • H164-377/2021E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: